Invitation
Dear Taiwan Urological Association,
On behalf of the Organizing Committee, we are delighted to invite your esteemed members to participate in the 2025 Asia Pacific Prostate Cancer Preceptorship (June 28-29, Shanghai), a premier platform dedicated to advancing prostate cancer care through multidisciplinary collaboration.
-
Draft Program: Attached for your reference (https://www.kcyx.org.cn/
newsinfo/8285814.html).
Exclusive Opportunity for Your Members:
We are pleased to offer 20 fully funded spots (airfare + accommodation) for qualified physicians, with two participation options:
-
Panelist
- Actively contribute as a discussant in themed sessions (e.g., "Metastatic Prostate Cancer Management").
- Share clinical insights and debate emerging therapies.
- Requirements: Submission of CV + proof of 5+ years' experience.
-
Attendee
- Engage through lectures and Q&A.
- Requirements: Valid medical license.
Selection is first-come, first-served. Should your members be interested, we warmly welcome them to contact us for further details.
Your society's involvement would greatly enrich this event. We look forward to hearing from you!
Warm regards,
Xinran LIANG
Organizing Committee, 2025 Asia Pacific Prostate Cancer Preceptorship
Email住址會使用灌水程式保護機制。你需要啟動Javascript才能觀看它
Agenda
2025前列腺癌亚太菁英会
2025 Asia Pacific Prostate Cancer Preceptorship
Date：2025.06.28-06.29
地点：上海浦东康桥万豪酒店
Venue：Shanghai Marriott Hotel Kangqiao
2025.06.28
|
大会主席Chairman：叶定伟教授Prof. Dingwei YE 执行主席Presiding Chairman：朱耀教授Prof. Yao ZHU | ||
|---|---|---|
|
时间Time（GMT+8） |
议程Topic |
讲者Speaker |
|
10:30-11:30 |
Hospital Visit to Fudan University Shanghai Cancer Center |
International speakers and attendees |
|
11:30-14:00 |
Lunch |
International speakers and attendees |
|
14:00 - 14:05 |
大会主席致辞 Welcome speech |
叶定伟Dingwei YE |
|
14:05 – 14:20 |
复旦大学附属肿瘤医院泌尿外科多学科团队介绍Introduction of multidisciplinary team of genitourinary cancers in Fudan University Shanghai Cancer Center |
戴 波Bo DAI |
|
14:20 – 14:35 |
香港大学癌症医学中心泌尿肿瘤团队介绍Introduction of multidisciplinary team of genitourinary cancers in Centre of Cancer Medicine University of Hong Kong |
李祖頴 Bryan Cho-Wing Li |
|
14:35– 14:50 |
日本老年泌尿生殖系统癌症患者多学科团队介绍Introduction of a Multidisciplinary Team for Older Genitourinary Cancer Patients in Japan |
成田伸太郎 Shintaro Narita |
|
14:50– 15:05 |
C中心泌尿肿瘤团队介绍Introduction of multidisciplinary team of genitourinary cancers in C |
|
|
15:05 – 15:20 |
D中心泌尿肿瘤团队介绍Introduction of multidisciplinary team of genitourinary cancers in D |
|
|
15:20 – 15:35 |
E中心泌尿肿瘤团队介绍Introduction of multidisciplinary team of genitourinary cancers in E |
|
|
15:35-15:40 |
总结 Summary |
|
|
15:40-17:00 |
学术部分Academic Contents |
|
|
Part One |
主旨报告 Keynote Speeches |
|
|
15:40 - 17:00 主持Chair：朱耀 Yao ZHU， |
||
|
15:40 – 16:00 |
TBD |
|
|
16:00 – 16:20 |
晚期前列腺癌的放射性配体疗法 Understanding Radioligand Therapies for Advanced Prostate Cancer |
|
|
16:20 – 16:50 |
肿瘤内微生物组与前列腺癌 Intratumoral Microbiome & Prostate Cancer |
Seok Joong Yun |
|
16:50 – 17:10 |
讨论Panel discussion |
|
|
17:10 – 17:20 会议总结 Closing |
||
2025.06.29
|
大会主席Chairman：叶定伟教授Prof. Dingwei YE 执行主席Presiding Chairman：朱耀教授Prof. Yao ZHU | ||
|---|---|---|
|
时间Time（GMT+8） |
议程Topic |
讲者Speaker |
|
08:30 - 08:35 |
主席致辞Welcome speech |
叶定伟 Dingwei YE 朱耀 Yao ZHU |
|
08:35-12:15 |
学术部分Academic Contents |
|
|
Part Two |
局限期前列腺癌的围手术期管理 Perioperative management of localized prostate cancer |
|
|
08:35 – 09:35 主持Chair： |
||
|
08:35 – 08:55 |
高危局限性前列腺癌激素治疗进展 Hormone Therapy in high risk localized prostate cancer |
成田伸太郎 Shintaro Narita |
|
08:55 – 09:15 |
生化复发患者的挽救性放疗：基于患者的方案制定 Salvage radiotherapy for patients with biochemical recurrence: patient-based approach |
林河清Martin Lam |
|
09:15 – 09:35 |
讨论Panel discussion |
|
|
Part Three |
转移性激素敏感前列腺癌的诊治进展 Updates in diagnosis and treatment of mHSPC |
|
|
09:35 – 10:55 主持Chair：邝维基Philip Kwong |
||
|
09:35 – 09:55 |
寡转移前列腺癌诊治的演变 Evolving Landscape of the Management of Oligometastatic Prostate Cancer |
戴波 Bo DAI |
|
09:55– 10:15 |
mHSPC的治疗降级：合理性及患者选择 De-escalation strategy in mHSPC： rationale and patient selection |
井上貴博 Takahiro Inoue |
|
10:15 – 10:35 |
PSA在前列腺癌中的临床价值 Clinical value of PSA in prostate cancer |
|
|
10:35 – 10:55 |
讨论Panel discussion |
|
|
Part Four |
转移性激素抵抗前列腺癌的诊治及临床试验 Theranostics and clinical trials of mCRPC |
|
|
10:55 – 12:15 主持Chair： |
||
|
10:55 – 11:15 |
PARP抑制剂的最佳使用：单药、联合或临床试验 Optimal use of PARP inhibitors: monotherapy, combination therapy, or clinical trial |
Chiong Edmund |
|
11:15 – 11:35 |
抗体偶联药物（ADC）在mCRPC阶段的探索与成果 Exploration and achievements of antibody-drug conjugates (ADCs) in mCRPC |
|
|
11:35 – 11:55 |
新的靶向治疗在mCRPC的探索与成果 Exploration and achievements of New target therapy in mCRPC |
李祖頴Cho Wing Bryan Li |
|
11:55 – 12:15 |
讨论Panel discussion |
|
|
12:15 – 12:25 结束致辞 Closing |
||